Keyphrases
Multilocus Approach
100%
Group Studies
100%
Genetic Interaction
100%
AIDS Clinical Trials
100%
Efavirenz
100%
Genetic Response
100%
ATP Binding Cassette Subfamily B Member 1 (ABCB1)
44%
Cytochrome P450 2D6 (CYP2D6)
44%
Virological Response
22%
Drug Transporter Genes
22%
Treatment Response
11%
Single nucleotide Polymorphism
11%
Drug-metabolizing Enzymes
11%
Polymorphism
11%
Antiretroviral
11%
Antiretroviral Therapy
11%
Nave
11%
Nucleoside Analogues
11%
Nelfinavir
11%
Enzyme Gene
11%
Long-term Response
11%
Single-Locus Model
11%
HIV-1 Reverse Transcriptase
11%
CYP3A5
11%
Cytochrome P450 3A4 (CYP3A4)
11%
CYP2C19
11%
Gene-gene Interaction
11%
Multifactor Dimensionality Reduction
11%
Efavirenz Pharmacokinetics
11%
Drug Metabolism Genes
11%
Neuroscience
Efavirenz
100%
Gene Interaction
100%
CYP2B6
40%
Blood Plasma
30%
Drug Metabolizing Enzyme
10%
Metabolic Pathway
10%
Human Immunodeficiency Virus
10%
Single-Nucleotide Polymorphism
10%
Nelfinavir
10%
Reverse-Transcriptase Inhibitor
10%
Cytochrome P450 3A4
10%
Cytochrome P450 2C19
10%
Nucleoside Analog
10%
Cytochrome P450 3A5
10%
Pharmacokinetics
10%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Efavirenz
100%
CYP2B6
40%
Drug Metabolizing Enzyme
10%
RNA Directed DNA Polymerase Inhibitor
10%
Drug Metabolism
10%
Cytochrome P450 3A5
10%
CYP2C19
10%
CYP3A4
10%
Nelfinavir
10%
Pharmacokinetics
10%
Nucleoside Analog
10%
Reverse Transcriptase
10%